Renhe Pharmacy Co., Ltd. logo

Renhe Pharmacy Co., Ltd. (000650)

Market Open
10 Aug, 06:57
XSHE XSHE
¥
5. 44
+0.01
+0.1842%
¥
8.47B Market Cap
- P/E Ratio
0.02% Div Yield
22.32M Volume
0 Eps
¥ 5.43
Previous Close
Add Transaction
Day Range
5.32 5.53
Year Range
4.85 7.02
Want to track 000650 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

000650 trading today higher at ¥5.44, an increase of 0.1842% from yesterday's close, completing a monthly increase of 7.7228% or ¥0.39. Over the past 12 months, 000650 stock lost -5.3913%.
000650 pays dividends to its shareholders, with the most recent payment made on Jul 17, 2026. The next estimated payment will be in In 11 months on Jul 17, 2027 for a total of ¥0.15182.
The last earnings report, released on May 23, 2025, exceeded the consensus estimates by 0.1187%. On average, the company has surpassed earnings expectations by 0.097%, based on the last three reports.
Renhe Pharmacy Co., Ltd. has completed 8 stock splits, with the recent split occurring on May 26, 2015.
The company's stock is traded on one exchange.

000650 Chart

People also search for

Dr Corp Ltd.
¥ 23.68
-1.0447%
Sunvim Group Co., Ltd.
¥ 11.97
-1.2376%
Tibet Gaozheng Explosive Co., Ltd.
¥ 59
-0.9735%
Innovative Medical Management Co., Ltd.
¥ 21.68
-1.0949%
Henan Liliang Diamond Co., Ltd.
¥ 58.62
-2.3488%

Renhe Pharmacy Co., Ltd. (000650) FAQ

What is the stock price today?

The current price is ¥5.44.

On which exchange is it traded?

Renhe Pharmacy Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000650.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.02%.

What is its market cap?

As of today, the market cap is 8.47B.

Has Renhe Pharmacy Co., Ltd. ever had a stock split?

Renhe Pharmacy Co., Ltd. had 8 splits and the recent split was on May 26, 2015.

Renhe Pharmacy Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Wujun Huang CEO
XSHE Exchange
CNE000000NF8 ISIN
CN Country
5,394 Employees
17 Jul 2026 Last Dividend
25 May 2012 Last Split
18 Nov 1996 IPO Date

Overview

Renhe Pharmacy Co., Ltd is a distinguished entity in the pharmaceutical sector, known for its extensive range of pharmaceutical products. Established in 1996, the company has entrenched its position in Nanchang, China, as a leading producer and supplier of pharmaceutical drugs and health-related products. Renhe Pharmacy has successfully combined the essence of traditional Chinese medicine with the advancements in Western medicines to cater to a broad spectrum of healthcare needs. Its commitment to quality and innovation has made it a trusted name among consumers and medical professionals alike.

Products and Services

  • Chinese and Western Medicines

    Renhe Pharmacy offers a comprehensive selection of medicines, including traditional Chinese medicines and Western pharmaceuticals. Their product range addresses a wide array of health conditions, effectively bridging the gap between ancient healing practices and modern medical science.

  • Raw Materials

    The company provides high-quality pharmaceutical raw materials, ensuring the production of safe and effective pharmaceutical products. These raw materials are crucial for the creation of various drugs and health supplements, maintaining the integrity of the final product.

  • Oral Solid Preparations

    This category includes tablets, capsules, and other solid forms designed for oral intake. Renhe Pharmacy utilizes advanced manufacturing processes to ensure these products meet strict quality standards for safety and effectiveness.

  • Liquid Preparations

    Comprising syrups, emulsions, and suspensions, these liquid formulations are developed for ease of use, especially for patients who find solid dosages challenging to consume. Renhe Pharmacy's liquid preparations are formulated to enhance patient compliance and absorption rates.

  • Large-Volume and Small-Volume Injections

    Renhe Pharmacy's range of injectables includes both large-volume injections for intravenous use and small-volume injections for subcutaneous or intramuscular administration. These are produced under the highest standards of sterility and precision, ensuring safety and efficacy.

  • External Lotions, Liniments, Suppositories, Ointments

    The company also specializes in the production of external applications such as lotions, liniments, suppositories, and ointments. These products are formulated for specific therapeutic needs, providing targeted relief and treatment to patients.

Contact Information

Address: Yuanchuang International, Area B, Nanchang, China, 330038
Phone: 86 791 8389 6755